UBS Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,386
| Closed | -$314K | – | 9337 |
|
|
2021
Q2 | $314K | Sell |
11,386
-86,174
| -88% | -$2.38M | ﹤0.01% | 4053 |
|
|
2021
Q1 | $1.61M | Buy |
97,560
+94,145
| +2,757% | +$1.55M | ﹤0.01% | 2955 |
|
|
2020
Q4 | $63K | Sell |
3,415
-28,890
| -89% | -$533K | ﹤0.01% | 4999 |
|
|
2020
Q3 | $440K | Buy |
32,305
+27
| +0.1% | +$368 | ﹤0.01% | 3521 |
|
|
2020
Q2 | $578K | Buy |
32,278
+9,903
| +44% | +$177K | ﹤0.01% | 3277 |
|
|
2020
Q1 | $223K | Sell |
22,375
-27,042
| -55% | -$270K | ﹤0.01% | 3816 |
|
|
2019
Q4 | $402K | Buy |
49,417
+34,468
| +231% | +$280K | ﹤0.01% | 4071 |
|
|
2019
Q3 | $148K | Buy |
14,949
+14,104
| +1,669% | +$140K | ﹤0.01% | 4587 |
|
|
2019
Q2 | $11K | Buy |
+845
| New | +$11K | ﹤0.01% | 6163 |
|
|
2018
Q4 | – | Sell |
-2,370
| Closed | -$24K | – | 7336 |
|
|
2018
Q3 | $24K | Buy |
+2,370
| New | +$24K | ﹤0.01% | 5796 |
|